OPRX compared with FC: revenue, margins and what each company keeps, and the suppliers and customers both name

OPRXOptimizeRx Corp

Mkt capRevenueRevenue

FCFranklin Covey Co

Mkt capRevenueRevenue

Compare

OPRXOptimizeRx Corp

FCFranklin Covey Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

OPRX

2 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±15.0%▲+24.72%×1.65

May 13 '26±17.6%▼−22.48%×1.28

Q1 FY26±18.6%▼−10.49%×0.56

Q3 FY25±20.8%▼−17.37%×0.84

1 of 3at or beyond implied

Reportimpliedrealized× implied

Nov 5 '26—▼−6.75%—

Q3 FY26±14.9%▼−12.85%×0.86

= impliedOPRX realized, solidFC realized, hatchedOne scale, both sides: full bar = 45%× = |realized| ÷ impliedSource: market data

Q2 FY26

±10.0%

▲+44.40%

×4.44

Jan 8 '26±10.6%▲+0.51%×0.05

OPRXOptimizeRx Corp

8.80▲+1.50%

Mkt cap$162.9MRevenue$21MQ2 FY26Revenue$109MFY25

FCFranklin Covey Co

16.13▼−0.20%

Regular sessionNov 6 '26

Mkt cap$195.7MRevenue$68MQ3 FY26Revenue$267MFY25

Compare

Regular sessionNov 6 '26

OPRXOptimizeRx Corp

FCFranklin Covey Co

8.80▲+1.50%

Price

16.13▼−0.20%

$162.9M

Mkt cap

$195.7M

Q2 FY26$21M

Revenue

$68MQ3 FY26

FY25$109M

Revenue

$267MFY25

OPRX8.80▲+1.50%vsFC16.13▼−0.20%Regular sessionNov 6 '26